Structure Database (LMSD)
| LM_ID | Common Name | Systematic Name | Main class | Sub class | Mass | Formula |
|---|---|---|---|---|---|---|
| LMSP0502AI06 | type IV H(d18:1/26:0) | Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] | 1675.02 | C82H150N2O32 |
| LMSP0502BM06 | Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] | 1675.02 | C82H150N2O32 | |
| LMSP0503AK06 | Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] | 1675.02 | C82H150N2O32 | |
| LMSP0504AE06 | type I B antigen(d18:1/26:0) | Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) | Neutral glycosphingolipids [SP05] | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504] | 1675.02 | C82H150N2O32 |
| LMSP0505CV06 | Gala 1-3Lex(d18:1/26:0) | Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) | Neutral glycosphingolipids [SP05] | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] | 1675.02 | C82H150N2O32 |
| LMSP0505AE06 | type II B antigen(d18:1/26:0) | Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) | Neutral glycosphingolipids [SP05] | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] | 1675.02 | C82H150N2O32 |